Equities

Asia Medical & Agricultural Laboratory & Research Center PCL

Asia Medical & Agricultural Laboratory & Research Center PCL

Actions
  • Price (THB)1.44
  • Today's Change0.02 / 1.41%
  • Shares traded238.00k
  • 1 Year change-15.29%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of THB
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1232273.11
Total Receivables, Net625152
Total Inventory10127.57
Prepaid expenses------
Other current assets, total0.190.290.16
Total current assets19529163
Property, plant & equipment, net394361340
Goodwill, net------
Intangibles, net212121
Long term investments10.00----
Note receivable - long term------
Other long term assets13129.34
Total assets649699448
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt03.908.01
Current portion long-term debt/capital leases313141
Other current liabilities, total6.335.9516
Total current liabilities666692
Total long term debt3860124
Total debt6996174
Deferred income tax16139.55
Minority interest------
Other liabilities, total151211
Total liabilities134151236
SHAREHOLDERS EQUITY
Common stock210210150
Additional paid-in capital276276--
Retained earnings (accumulated deficit)286262
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity514548212
Total liabilities & shareholders' equity649699448
Total common shares outstanding420420420
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.